clinical trial · NCT05597020
A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia
Insomnia DisorderNocturiaDaridorexantPlacebo
brief summary
A study to find out if daridorexant is safe and efficacious in patients with insomnia and comorbid nocturia
started
Feb 16, 2023
primary completion
Apr 12, 2024
completion
Apr 18, 2024
last updated
Apr 18, 2025
official title
A Multi-center, Double-blind, Randomized, Placebo-controlled, 2-way Cross-over Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol